Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.
The diversity of antidepressant mechanisms available today allows clinicians to individualize treatment decisions for depressive symptoms and subtypes, as well as to avoid side effects. The mechanism of action of antidepressants allows prediction of both adverse effects and therapeutic effects. Individual antidepressants have unique psychopharmacologic profiles, and individual patients have unique clinical profiles of different symptoms and depressive subtypes. By using this knowledge, the prescriber can match drug profiles with patient profiles to select preferred agents and avoid less preferred agents.
Stahl
S M
SM
Department of Psychiatry, University of California San Diego and Clinical Neuroscience Research Center, 92122, USA.
D000928:Antidepressive Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D003511:Cyclohexanols / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D011307:Drug Prescriptions; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010879:Piperazines; D011985:Receptors, Serotonin / Q000187:drug effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D000069470:Venlafaxine Hydrochloride
D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D016642:Bupropion; D003511:Cyclohexanols; D008996:Monoamine Oxidase Inhibitors; D010879:Piperazines; D011985:Receptors, Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D014230:Triazoles; D000069470:Venlafaxine Hydrochloride; C051752:nefazodone